Patient-Centred Innovations for Persons with Multimorbidity: funded evaluation protocol
- PMID: 28487349
- PMCID: PMC5498229
- DOI: 10.9778/cmajo.20160097
Patient-Centred Innovations for Persons with Multimorbidity: funded evaluation protocol
Abstract
Background: The high prevalence of multimorbidity necessitates rethinking of the health care system. The overarching goal of the Patient-Centred Innovations for Persons with Multimorbidity program is to build on existing structures and find and evaluate patient-centred innovations relevant to multimorbidity.
Methods: We describe the protocol for a proposed multijurisdictional (Quebec and Ontario) concurrent triangulation mixed-methods study. In both provinces, a qualitative descriptive study will be used to explore innovations in patient-centred multimorbidity care. Two randomized controlled trials, 1 in either province, will evaluate the innovations in a wait-list-controlled design using patient-reported outcomes. An additional control group, matched on age, sex, enrolment/index date (± 3 mo) and propensity score, will be created with the use of health administrative data. Patients will be 18-80 years of age and will have 3 or more chronic conditions. The innovations will have elements of relevance to multimorbidity care, patient-centred partnerships and integration of care. The primary outcome measures will be 2 patient-reported outcomes: patient education and self-efficacy. Secondary outcomes will include patient-reported health status, quality of life, psychological distress and health behaviours, and costs of care.
Interpretation: This protocol describes a mixed-method study in 2 jurisdictions. The studies will answer the questions of what innovations work and how they work for patients, health care professionals and policy-makers. Trial registration: ClinicalTrials.gov, no NCT02789800 (Quebec Trial), NCT02742597 (Ontario Trial).
Copyright 2017, Joule Inc. or its licensors.
Conflict of interest statement
Competing interests: Sonja Reichert reports grants from the Canadian Institutes of Health Research during the conduct of the study, personal fees from Janssen, Eli Lilly, Servier, Merck and Abbott outside the submitted work, and grants and personal fees from Sanofi, AstraZenica, Novo Nordisk and Boehringer Ingelheim outside the submitted work. No other competing interests were declared. Neither the coprincipal investigators nor the site leads have conflicts of interest to declare.
Figures
References
-
- Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294:716–24. - PubMed
-
- Du S, Yuan C. Evaluation of patient self-management outcomes in health care: a systematic review. Int Nurs Rev. 2010;57:159–67. - PubMed
-
- Hutchison B. A long time coming: primary healthcare renewal in Canada. Healthc Pap. 2008;8:10–24. - PubMed
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical